How to get into a clinical trial? Understanding inclusion and exclusion criteria

When determining which clinical trial is the right fit, many factors must be considered. The site location, the number of required visits, and the length of the study are all important considerations, but before any of this, it is vital to consider the study's inclusion and exclusion criteria.

Continue reading

What happens in each clinical trial phase? [infographic]

Before any new treatment is able to be approved, it is required to go through the vigorous testing process known as clinical trials. These trials are aimed at determining whether or not a drug, medical device, therapy, or other type of intervention is safe and effective for the public.

Continue reading

Human factor clinical trial recruitment strategies

Though clinical trials are often discussed in the context of medications and therapies, the devices that administer these medications must also be approved by the FDA before they can be released to market. This requirement includes tools patients and medical professionals use, such as inhalers, insulin injectors, auto-injectors for epinephrine, and devices that administer injectable medications.

Continue reading

Announcing Antidote Pulse™: Real-time reporting for better recruitment

When recruiting patients for a clinical trial, using data is one of the best ways to make informed decisions about study management. From understanding where patients are in the funnel to which sites are receiving too much volume, accessing the metrics that drive these decisions should be simple — and with Antidote’s Pulse™ software, it is.

Continue reading

DIA in review: Charting new horizons in clinical trials

Antidote was thrilled to attend the 2024 DIA Conference in San Diego last week! Not only was it a lovely opportunity to connect with many industry professionals and learn from experts, but it was also the celebration of 60 years of DIA. In case you missed it, we’re sharing some of our key takeaways from the four-day event, which focused on charting new horizons in clinical trials.

Continue reading

Clinical trial recruitment strategies for successful patient enrollment

Though collecting accurate data, keeping precise records, and measuring results are all complex tasks involved with medical research, clinical trial recruitment and enrollment are often cited as the most challenging part of the process. Not only is having a large enough sample size essential for research integrity, but recruitment delays can also be extremely costly. By some estimates, delays in ...

Continue reading

Why participating in research can be a rewarding experience

When considering joining a clinical trial, many individuals may feel unsure if it is the right choice for them. There are many things to consider when making this decision, and it is a personal one — but making the choice to participate in medical studies can be rewarding in many ways.

Continue reading

What to know about endometrial cancer

Also known as endometrial carcinoma or uterine cancer, endometrial cancer occurs when the cells that line the uterus begin growing uncontrollably. Though the mortality rates are relatively low due to the high rate of early detection, it is a cancer that impacts nearly 70,000 people every year.

Continue reading

How clinical trial patient recruitment and retention work together

Recruiting and retaining patients are two of the most challenging aspects of clinical trials. The average clinical trial must extend its recruitment timeline by 71%, and up to 30% of patients will eventually drop out. While patients can leave a trial if it is not a good fit for them, there are patient-centric approaches that can make enrolling and participating in a study a more enjoyable ...

Continue reading

On National Cancer Survivors Day, celebrating the power of research

This Sunday, June 2, is National Cancer Survivors Day, designed to be a celebration for those who have survived cancer and an inspiration for those recently diagnosed. Since 1991, the national cancer death rate has dropped by 33%, partially due to advancements in treatment, early detection, and reduced smoking rates.

Continue reading

Get our latest posts in your inbox